Related Experiment Video
Updated: May 10, 2026

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
Maternal high-fat diet disrupts intestinal mucus barrier of offspring by regulating gut immune receptor LRRC19
Yue Sun1,2, Shumin Huang1, Mengfan Li1
1Department of Gastroenterology and Hepatology, Tianjin Medical University General Hospital, Tianjin Key Medical Discipline (Specialty), Tianjin Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, Tianjin, 300052, China.
Insights
Maternal high-fat diet impairs offspring gut mucus barrier via LRRC19. Deleting leucine-rich repeat C19 (LRRC19) restores barrier function and beneficial bacteria, suggesting a novel therapeutic target.
Area of Science:
- Immunology
- Microbiology
- Gastroenterology
Background:
- Maternal high-fat diet (MHFD) increases offspring susceptibility to colitis.
- The underlying mechanisms for MHFD-induced gut dysfunction remain unclear.
Purpose of the Study:
- To investigate the role of the gut immune receptor leucine-rich repeat C19 (LRRC19) in MHFD-induced gut barrier impairment.
- To explore the impact of LRRC19 on gut immune response and microbiota composition in offspring exposed to MHFD.
Main Methods:
- Mice were exposed to MHFD during gestation.
- Intestinal mucus barrier integrity, LRRC19 expression, gut microbiota composition (metagenome sequencing), and targeted metabolomics were analyzed.
- Lrrc19 knockout (Lrrc19-/-) mice were used to assess the protective effects of LRRC19 deletion.
Main Results:
- MHFD significantly impaired the intestinal mucus barrier and upregulated LRRC19 expression in offspring.
- Lrrc19 deletion alleviated mucus barrier disruption and partially restored MHFD-induced gut microbiota alterations.
- Lrrc19-/- offspring showed increased Akkermansia muciniphila and Lactobacillus reuteri, a producer of indole-3-acetic acid (IAA).
- IAA improved mucus barrier function by enhancing IL-22+ ILC3 cells via the AhR pathway.
Conclusions:
- MHFD disrupts the offspring intestinal mucus barrier by regulating the gut immune receptor LRRC19.
- Imbalances in gut microbiota and metabolites, particularly IAA, play a crucial role in MHFD-induced gut dysfunction.
- Targeting LRRC19 and modulating gut microbiota-derived metabolites like IAA may offer therapeutic strategies against MHFD-related gut issues.
Abstract:
Maternal high fat diet (MHFD) increased colitis susceptibility in adulthood. However, the mechanism remains unclear. We sought to explore whether novel gut immune receptor leucine-rich repeat C19 (LRRC19) contributed to the impaired mucus barrier of offspring exposed to MHFD via gut immune response and microbiota. The results showed that MHFD significantly impaired the intestinal mucus barrier of offspring, and up-regulated the expression of LRRC19. Lrrc19 deletion alleviated the mucus barrier disruption. Mechanistically, metagenome sequencing revealed that the MHFD-induced gut microbiota alteration was partly restored in Lrrc19-/- offspring. Muc2-associated bacteria were decreased in the MHFD group, such as Akkermansia_muciniphila_CAG_154, which increased in the Lrrc19-deficient offspring. Moreover, Lrrc19-/- offspring had a higher rate of indole-3-acetic acid (IAA)-producing bacterium, such as Lactobacillus reuteri. A targeted metabolomics analysis revealed that IAA emerged as the top candidate that might mediate the protective effects. IAA was found to improve the mucus barrier function by increasing the ratio of interleukin-22 (IL-22)+ ILC3 cells in an aryl hydrocarbon receptor (AhR)-dependent manner. These results suggest that MHFD disrupts the intestinal mucus barrier of offspring through regulating gut immune receptor LRRC19 and inducing an imbalance of gut microbiota and microbiota-derived metabolites.
More Related Videos
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
09:09Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022